Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1Lymphoid 1

Conditions

Leukemia 23Leukemia, Myeloid, Acute 22Precursor Cell Lymphoblastic Leukemia-Lymphoma 21Multiple Myeloma 17Lymphoma, Non-Hodgkin 17Leukemia, Lymphocytic, Chronic, B-Cell 17Lymphoma, Follicular 16Myelodysplastic Syndromes 15Lymphoma, Mantle-Cell 15Lymphoma 15Leukemia, Myeloid, Accelerated Phase 14Hodgkin Disease 14Blast Crisis 13Leukemia, Myelomonocytic, Chronic 12Lymphoma, Large-Cell, Immunoblastic 11Leukemia, Myeloid, Chronic-Phase 11Burkitt Lymphoma 11Ovarian Neoplasms 10Myeloproliferative Disorders 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma, B-Cell, Marginal Zone 10Congenital Abnormalities 10Neoplasms, Plasma Cell 9Breast Neoplasms 9Waldenstrom Macroglobulinemia 7Polycythemia Vera 7Leukemia, Biphenotypic, Acute 7Thrombocythemia, Essential 6Primary Myelofibrosis 6Carcinoma, Ovarian Epithelial 6

Interventions

eltrombopag 3romiplostim 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Cytarabine 2Busulfan 2Vitamin E 1Tranexamic Acid 1Topotecan 1Thrombopoietin 1Saline Solution 1Radiotherapy 1Moxibustion 1Microarray Analysis 1Isotretinoin 1Ifosfamide 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Doxorubicin 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cord Blood Stem Cell Transplantation 1Carboplatin 1CP protocol 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Thrombocytopenia × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00003619 2013-06-26

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00305708 2012-11-12

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

University of California, San Francisco

Phase 1/2 Completed
40 enrolled
Classical hematologyOther hematologic neoplasm

Congenital amegakaryocytic thrombocytopenia, Neutropenia, Severe Congenital, Autosomal Recessive 3, Fanconi Anemia, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Chronic-Phase, Anemia, Diamond-Blackfan

Data powered by HemOnc (CC BY 4.0) Colophon âš¡